The TyG-CD4 stratification model proposed in this study is designed to address this heterogeneity by integrating two key dimensions of host vulnerability: immune dysfunction (CD4 count) and metabolic dysregulation (TyG index). The gene discussed is CD4; the disease is immune system disorder.